← Leaderboards
Satheesh Chonat
Emory University
$1,710,969
Attributed
$2,030,657
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $707.1K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,030,657 · 2
By mechanism
R01$1,391,280 · 1
R21$639,377 · 1
Top collaborators
- Yongzhi Qiu3 shared
Most similar at Emory University
Same institution · by research overlap
- Susan Creary$2,068,115
- Sean R Stowell$18,165,764
- Clinton H. Joiner$9,117,959
- James C. Zimring$24,599,687
- Wilbur A Lam$39,688,140
Others in their field
Other Emerging Leaders on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$91,415,673
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
Research focus
InsightNovel TherapeuticsExhibitsInjuryMediatingMortalityComplement PathwayErythrocytesFunctional DisorderHemolytic AnemiaIn VivoLifeAffectMolecularAlternative Complement PathwayComplement ActivationAcuteEndotheliumAnimal ModelChronicCessation Of LifeHemeComplementPathogenesis
Grant awards (5)
Complement in the Pathogenesis of Acute Chest Syndrome$684,204
R01 · FY2025 · HL · contact PI
Complement in the Pathogenesis of Acute Chest Syndrome$707,076
R01 · FY2024 · HL · contact PI
Modeling atypical hemolytic uremic syndrome with hydrogel-based microvasculature-on-chip technologies$234,445
R21 · FY2021 · EB
Modeling atypical hemolytic uremic syndrome with hydrogel-based microvasculature-on-chip technologies$195,470
R21 · FY2020 · EB
Modeling atypical hemolytic uremic syndrome with hydrogel-based microvasculature-on-chip technologies$209,462
R21 · FY2019 · EB